Fineline Cube

Follow:
14409 Articles
Takeda Zasocitinib TYK2 Phase III Shows Positive Psoriasis Results
CompanyDrug

Takeda Zasocitinib TYK2 Phase III Shows Positive Psoriasis Results

Lilly Imlunestrant Breast-Cancer EMBER-3 Shows 38% Risk Reduction
CompanyDrug

Lilly Imlunestrant Breast-Cancer EMBER-3 Shows 38% Risk Reduction

IVIEW GVB-2001 Gene Therapy Treats First POAG Patient Successfully
CompanyDrug

IVIEW GVB-2001 Gene Therapy Treats First POAG Patient Successfully

Novartis MSD Sanofi TrumpRx Deal Targets Medicaid Pricing
Company

Novartis MSD Sanofi TrumpRx Deal Targets Medicaid Pricing

Novabio’s Treg Therapy NP001 Doses First ALS Patient in China Trial
CompanyDrug

Novabio’s Treg Therapy NP001 Doses First ALS Patient in China Trial

Grand Pharmaceutical’s TLX591‑CDx RDC Wins China Phase III for Prostate Cancer Diagnosis
CompanyDrug

Grand Pharmaceutical’s TLX591‑CDx RDC Wins China Phase III for Prostate Cancer Diagnosis

MiniMed Diabetes Files for IPO, Seeking Nasdaq Listing as MMED
CompanyDeals

MiniMed Diabetes Files for IPO, Seeking Nasdaq Listing as MMED

Simcere Zaiming Licenses ADC SIM0613 to Ipsen in $1.06 Billion Deal
CompanyDeals

Simcere Zaiming Licenses ADC SIM0613 to Ipsen in $1.06 Billion Deal

Merck’s Pimicotinib Wins China Approval as First Class 1 Therapy for TGCT
CompanyDrug

Merck’s Pimicotinib Wins China Approval as First Class 1 Therapy for TGCT

GSK’s Nucala Wins China Approval as First IL‑5 Biologic for COPD
CompanyDrug

GSK’s Nucala Wins China Approval as First IL‑5 Biologic for COPD

EPI-003 Wins FDA IND as First LNP Epigenetic Therapy for Hepatitis B
CompanyDrug

EPI-003 Wins FDA IND as First LNP Epigenetic Therapy for Hepatitis B

SanegeneBio’s INHBE siRNA Wins China IND for Obesity as First RNAi Target
CompanyDrug

SanegeneBio’s INHBE siRNA Wins China IND for Obesity as First RNAi Target